As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Aurora Cannabis reported 37% revenue growth in its most recent quarter. The company also posted a profit. The international medical cannabis market has played a key role in its recent rapid growth.

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also suggests that the stock is experiencing more of a short cover rally ...

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased ...

Aurora Cannabis reported Q3 FY25 net revenue of CA$88.2M, driven by rise in medical cannabis sales and plant propagation. Adjusted EBITDA surged 316% to CA$23.1M, with adjusted gross margin ...